BRKR – bruker corporation (US:NASDAQ)

News

Bruker Corporation to Present at Upcoming Investor Conferences
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $75.00. They now have a "buy" rating on the stock.
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at TD Cowen from $72.00 to $70.00. They now have a "hold" rating on the stock.
Bruker Co. (NASDAQ: BRKR) had its price target lowered by analysts at Wells Fargo & Company from $78.00 to $75.00. They now have an "overweight" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com